Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Up 21.2% in January

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) saw a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 1,192,172 shares, a growth of 21.2% from the January 15th total of 983,500 shares. Based on an average daily volume of 60 shares, the short-interest ratio is currently 19,869.5 days. Based on an average daily volume of 60 shares, the short-interest ratio is currently 19,869.5 days.

Shanghai Fosun Pharmaceutical (Group) Price Performance

SFOSF stock opened at $2.61 on Thursday. Shanghai Fosun Pharmaceutical has a twelve month low of $1.62 and a twelve month high of $3.50. The business’s 50-day simple moving average is $2.80 and its 200 day simple moving average is $2.96.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.